Epidemiology of Primary CNS Tumors in Iran: A Systematic Review

  • Jazayeri, Seyed Behzad (Sina Trauma and Research Center, Tehran University of Medical Sciences) ;
  • Rahimi-Movaghar, Vafa (Sina Trauma and Research Center, Tehran University of Medical Sciences) ;
  • Shokraneh, Farhad (Research Center for Pharmaceutical Nanotechnology and Iranian Center for EBM, Tabriz University of Medical Sciences) ;
  • Saadat, Soheil (Sina Trauma and Research Center, Tehran University of Medical Sciences) ;
  • Ramezani, Rashid (Ministry of Health, Center for Disease Control and Prevention, Non-communicable Diseases Unit, Cancer Office)
  • Published : 2013.06.30


Background: Although primary malignant CNS tumors are registered in the national cancer registry (NCR) of Iran, there are no available data on the incidence of the primary malignant or benign CNS tumors and their common histopathologies in the country. This study analyzed the 10-year data of the Iranian NCR from March 21, 2000 to March 20, 2010, including a systematic review. Materials and Methods: The international and national scientific databases were searched using the search keywords CNS, tumor, malignancy, brain, spine, neoplasm and Iran. Results: Of the 1,086 primary results, 9 papers were selected and reviewed, along with analysis of 10-year NCR data. The results showed that primary malignant brain tumors have an overall incidence of 2.74 per 100,000 person-years. The analysis of the papers revealed a benign to malignant ratio of 1.07. The most common histopathologies are meningioma, astrocytoma, glioblastoma and ependymoma. These tumors are more common in men (M/F=1.48). Primary malignant spinal cord tumors constitute 7.1% of the primary malignant CNS tumors with incidence of 0.21/100,000. Conclusions: This study shows that CNS tumors in Iran are in compliance with the pattern of CNS tumors in developing countries. The NCR must include benign lesions to understand the definitive epidemiology of primary CNS tumors in Iran.


  1. Alimi M, Rahimi-Movaghar V (2012). Biographical sketch: Nosrat ollah ameli, mb, chb (hons), chm (birm), fics, frcs (eng). Br J Neurosurg, 26, 630-6.
  2. Ameli N, Hadadian A, Kamalian N (1979). Incidence of intracranial tumors in iran. Neurosurg Rev, 2, 67-71.
  3. Anonymous (2000-9). Iranian annual of national cancer registry report. Annual Report of National Cancer Registry. Ministry of Health C. F. D. C. P., Noncommunicable Diseases Unit, Cancer Office. Tehran, Ministry of Health.
  4. Ardehali MR (1990). Relative incidence of spinal canal tumors. Clin Neurol Neurosurg, 92, 237-43.
  5. Babaei M, Mousavi S, Malek M, et al (2005). Cancer occurrence in semnan province, iran: Results of a population-based cancer registry. Asian Pac J Cancer Prev, 6, 159-64.
  6. Baldi I, Gruber A, Alioum A, et al (2011). Descriptive epidemiology of cns tumors in france: Results from the gironde registry for the period 2000-2007. Neuro Oncol, 13, 1370-8.
  7. Bauchet L, Rigau V, Mathieu-Daude H, et al (2007). French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol, 84, 189-99.
  8. Bondy ML, Scheurer ME, Malmer B, et al (2008). Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer, 113, 1953-68.
  9. Cheang CM, Hwang SL, Hwong SL (1997). An analysis of intraspinal tumors in south taiwan. Kaohsiung J Med Sci, 13, 229-36.
  10. Davis FG, Mccarthy BJ, Berger MS (1999). Centralized databases available for describing primary brain tumor incidence, survival, and treatment: central brain tumor registry of the united states; surveillance, epidemiology, and end results; and national cancer data base. Neuro Oncol, 1, 205-11.
  11. Deltour I, Johansen C, Auvinen A, et al (2009). Time trends in brain tumor incidence rates in denmark, finland, norway, and sweden, 1974-2003. J Natl Cancer Inst, 101, 1721-4.
  12. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006). Trends in brain cancer incidence and survival in the united states: Surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus, 20, 1.
  13. Dobes M, Shadbolt B, Khurana VG, et al (2011). A multicenter study of primary brain tumor incidence in australia (2000-2008). Neuro Oncol, 13, 783-90.
  14. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012). Cbtrus statistical report: Primary brain and central nervous system tumors diagnosed in the united states in 2005-2009. Neuro-Oncol, 14, 1-49.
  15. Etemadi A, Sadjadi A, Semnani S, et al (2008). Cancer registry in iran: A brief overview. Arch Iran Med, 11, 577-80.
  16. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer, 127, 2893-917.
  17. Habibi A (1962). Cancer in iran. Statistical data for the most frequent forms. Rev Med Moyen Orient, 19, 302-8.
  18. Kaneko S, Nomura K, Yoshimura T, Yamaguchi N (2002). Trend of brain tumor incidence by histological subtypes in japan: Estimation from the brain tumor registry of japan, 1973- 1993. J Neurooncol, 60, 61-9.
  19. Ketabchi S,Ghodsi S (1989). A ten year review of brain tumors in tehran university of medical sciences. Tehran Medical University Journal, 47, 43-7.
  20. Kurland LT, Schoenberg BS, Annegers JF, Okazaki H, Molgaard CA (1982). The incidence of primary intracranial neoplasms in rochester, minnesota, 1935-1977. Ann NY Acad Sci, 381, 6-16.
  21. Larijani B, Shirzad M, Mohagheghi MA, et al (2004). Epidemiologic analysis of the tehran cancer institute data system registry (tcidsr). Asian Pac J Cancer Prev, 5, 36-9.
  22. Lee CH, Jung KW, Yoo H, Park S, Lee SH (2010). Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc, 48, 145-52.
  23. Listed NA (1977). Esophageal cancer studies in the caspian littoral of iran: Results of population studies--a prodrome. Joint iran-international agency for research on cancer study group. J Natl Cancer Inst, 59, 1127-38.
  24. Lopez-Abente G, Pollan M, Ardanaz E, Errezola M (2003). Geographical pattern of brain cancer incidence in the navarre and basque country regions of spain. Occup Environ Med, 60, 504-8.
  25. Mahzoni P, Mohammadizadeh F (2003). Gradings and properties of primary brain tumors of al-zahra hospital in esfahan based on who grading scale. J Lorestan Med Univ, 6, 59-64.
  26. Manoharan N, Julka P, Rath G (2012). Descriptive epidemiology of primary brain and cns tumors in delhi, 2003-2007. Asian Pac J Cancer Prev, 13, 637-40.
  27. Mehrazin M, Rahmat H, Yavari P (2006). Epidemiology of primary intracranial tumors in iran, 1978-2003. Asian Pac J Cancer Prev, 7, 283-8.
  28. Meshkini A, Fakhrjo A, Fathi A (2000). Prevalence of central nervous system tumors-a single center ten years study of imam khomeyni hospital of tabriz. Tabriz Medical University J, 31, 76-82.
  29. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in tehran metropolis: The first report from the tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12, 15-23.
  30. Moher D, Liberati A, Tetzlaff J, Altman DG (2010). Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. Int J Surg, 8, 336-41.
  31. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in iran. Ann Oncol, 20, 556-63.
  32. Ostrom QT, Barnholtz-Sloan JS (2011). Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep, 11, 329-35.
  33. Pirouzmand F, Sadanand V (2007). The incidence trends of primary brain tumors in saskatchewan from 1970-2001. Can J Neurol Sci, 34, 181-6.
  34. Reyhani-Kermani H (2003). An epidemiologic survey on brain tumors in kerman from 1997. Teb Jonoub J, 7, 1.
  35. Rezaee O, Hadadian K (1997). A ten year review of spinal cord tumors in loghman hakim hospital. Res Med J, 24, 227-35.
  36. Seddighi A, Seddighi A, Ashrafi F, Nohehsara S (2010). Neuropsychological disorders in patients with brain tumor. Iran J Cancer Prev, 3, 42-7.
  37. Surawicz TS, Mccarthy BJ, Kupelian V, et al (1999). Descriptive epidemiology of primary brain and cns tumors: Results from the central brain tumor registry of the united states, 1990-1994. Neuro Oncol, 1, 14-25.
  38. Wahl CJ, Tubbs RS, Spencer DD, Cohen-Gadol AA (2009). Harvey cushing as a book collector, bibliophile, and archivist: The precedence for the genesis of the brain tumor registry. Historical vignette. J Neurosurg, 111, 1091-5.

Cited by

  1. Overview of Cancer Registration Research in the Asian Pacific from 2008-2013 vol.14, pp.8, 2013,
  2. One-year Survival Rate of Patients with Primary Malignant Central Nervous System Tumors after Surgery in Kazakhstan vol.15, pp.16, 2014,
  3. Efficacy of High Dose Radiotherapy in Post-operative Treatment of Glioblastoma Multiform - A Single Institution Report vol.15, pp.6, 2014,
  4. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis vol.17, pp.6, 2014,
  5. Clinicopathological Findings and Five Year Survival Rates for Patients with Central Nervous System Tumors in Yazd, Iran vol.15, pp.23, 2015,
  6. Epidemiological Trends of Histopathologically WHO Classified CNS Tumors in Developing Countries: Systematic Review vol.16, pp.1, 2015,
  7. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression vol.16, pp.16, 2015,
  8. Meningeal Hemangiopericytomas and Meningomas: a Comparative Immunohistochemical and Genetic Study vol.16, pp.16, 2015,
  9. Malignant Tumors of the Central Nervous System in Kazakhstan: Component Analysis of Incidence Dynamics vol.16, pp.6, 2015,
  10. Prevalence of JC polyomavirus large T antigen sequences among Iranian patients with central nervous system tumors vol.160, pp.1, 2015,
  11. Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study vol.11, pp.5, 2016,
  12. Comprehensive analysis of Iranian reports of pediatric central nervous system tumors vol.33, pp.9, 2017,
  13. Management and outcomes of treating pediatric medulloblastoma: an eight years’ experience in an Iranian pediatric center pp.1433-0350, 2017,
  14. Tea and coffee consumption in relation to glioma: a case-control study pp.1436-6215, 2017,
  15. Emergence of Convolutional Neural Network in Future Medicine: Why and How. A Review on Brain Tumor Segmentation vol.24, pp.1, 2018,
  16. Dietary Polyunsaturated Fat Intake in Relation to Glioma: A Case-Control Study pp.1532-7914, 2018,